Gene profiling suggests a common evolution of bladder cancer subtypes

BMC Medical Genomics

Volumn 6, Issue 1, 2013, Pages

  Hansel, Donna E ^a   Zhang, Zhongfa ^b   Petillo, David ^b   Teh, Bin T ^c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VAN ANDEL RESEARCH INSTITUTE   (United States)

^c DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^d DUKE NUS MEDICAL SCHOOL   (Singapore)

Author keywords

Bladder cancer; Gene expression profiling; Squamous; Subtype; Urothelial

Indexed keywords

ADH1B GENE; AOX1 GENE; ARTICLE; AURKA GENE; BLADDER CANCER; BLADDER SQUAMOUS CELL CARCINOMA; CANCER CLASSIFICATION; CANCER RISK; CELL CYCLE; CLINICAL ARTICLE; CONTROLLED STUDY; DESMOSOME; E CADHERIN GENE; GENE; GENE CLUSTER; GENE CONTROL; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; HLA DQ1 GENE; HUMAN; HUMAN TISSUE; INTERMEDIATE FILAMENT; MOLECULAR EVOLUTION; PHENOTYPE; PRIORITY JOURNAL; RACGAP1 GENE; RISK FACTOR; SCUBE2 GENE; SMOKING; SQUAMOUS CELL CARCINOMA; SQUAMOUS EPITHELIUM; TOPOISOMERASE GENE; TRANSITIONAL CELL CARCINOMA; UGT1A10 GENE; UGT1A7 GENE; UPREGULATION; UROTHELIUM;

UCA;

CLUSTER ANALYSIS; EVOLUTION, MOLECULAR; GENE EXPRESSION PROFILING; HUMANS; URINARY BLADDER NEOPLASMS;

EID: 84885488684     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-6-42     Document Type: Article

References (36)

1. Urothelial tumorigenesis: a tale of divergent pathways. Wu XR, Nat Rev Cancer 2005 5 713 725 10.1038/nrc1697 16110317 (Pubitemid 41486364)
2. ICUD-EAU international consultation on bladder cancer 2012: pathology. Amin MB, McKenney JK, Paner GP, Hansel DE, Grignon DJ, Montironi R, Lin O, Jorda M, Jenkins LC, Soloway M, et al. Eur Urol 2013 63 16 35 10.1016/j.eururo.2012. 09.063 23083804
3. Squamous cell carcinoma of the bladder: a clinicopathologic analysis of 45 cases. Lagwinski N, Thomas A, Stephenson AJ, Campbell S, Hoschar AP, El-Gabry E, Dreicer R, Hansel DE, Am J Surg Pathol 2007 31 1777 1787 10.1097/PAS.0b013e31805c9cd9 18043032 (Pubitemid 350175805)
4. Eble JN, Sauter G, Epstein JI, Sesterhenn IA, Pathology and genetics of tumours of the urinary system and male genital organs Lyon, France: IARC Press 2004
5. Gene expression profile in squamous cell carcinoma of the urinary bladder using complementary deoxyribonucleic acid microarray. Ewis AA, El-Samman E, Ali N, Kajimoto K, Shinohara Y, Ishikawa M, Kanayama HO, Baba Y, Urol Oncol 2007 25 120 127 10.1016/j.urolonc.2006.03.006 17349526 (Pubitemid 46349745)
6. Bladder cancer outcome and subtype classification by gene expression. Blaveri E, Simko JP, Korkola JE, Brewer JL, Baehner F, Mehta K, Devries S, Koppie T, Pejavar S, Carroll P, et al. Clin Cancer Res 2005 11 4044 4055 10.1158/1078-0432.CCR-04-2409 15930339 (Pubitemid 40791568)
7. Molecular profiling of bladder cancer using cDNA microarrays: defining histogenesis and biological phenotypes. Sanchez-Carbayo M, Socci ND, Charytonowicz E, Lu M, Prystowsky M, Childs G, Cordon-Cardo C, Cancer Res 2002 62 6973 6980 12460915 (Pubitemid 35424089)
8. Proteome profiling of bladder squamous cell carcinomas: identification of markers that define their degree of differentiation. Ostergaard M, Rasmussen HH, Nielsen HV, Vorum H, Orntoft TF, Wolf H, Celis JE, Cancer Res 1997 57 4111 4117 9307301 (Pubitemid 27427705)
9. Comparative gene expression profiling analysis of urothelial carcinoma of the renal pelvis and bladder. Zhang Z, Furge KA, Yang XJ, Teh BT, Hansel DE, BMC Med Genomics 2010 3 58 10.1186/1755-8794-3-58 21159190
10. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bolstad BM, Irizarry RA, Astrand M, Speed TP, Bioinformatics 2003 19 185 193 10.1093/bioinformatics/19.2.185 12538238 (Pubitemid 36181903)
11. Summaries of affymetrix GeneChip probe level data. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP, Nucleic Acids Res 2003 31 15 10.1093/nar/gng015 12582260
12. APE: analyses of Phylogenetics and Evolution in R language. Paradis E, Claude J, Strimmer K, Bioinformatics 2004 20 289 290 10.1093/bioinformatics/ btg412 14734327 (Pubitemid 38195693)
13. Amplification/overexpression of a mitotic kinase gene in human bladder cancer. Sen S, Zhou H, Zhang RD, Yoon DS, Vakar-Lopez F, Ito S, Jiang F, Johnston D, Grossman HB, Ruifrok AC, et al. J Natl Cancer Inst 2002 94 1320 1329 10.1093/jnci/94.17.1320 12208897
14. The investigational aurora kinase a inhibitor MLN8237 induces defects in cell viability and cell-cycle progression in malignant bladder cancer cells in vitro and in vivo. Zhou N, Singh K, Mir MC, Parker Y, Lindner D, Dreicer R, Ecsedy JA, Zhang Z, Teh BT, Almasan A, et al. Clin Cancer Res 2013 19 1717 1728 10.1158/1078-0432.CCR-12-2383 23403633
15. Gene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival. Landi MT, Dracheva T, Rotunno M, Figueroa JD, Liu H, Dasgupta A, Mann FE, Fukuoka J, Hames M, Bergen AW, et al. PLoS One 2008 3 1651 10.1371/journal.pone.0001651 18297132 (Pubitemid 351865456)
16. The forkhead Box m1 transcription factor stimulates the proliferation of tumor cells during development of lung cancer. Kim IM, Ackerson T, Ramakrishna S, Tretiakova M, Wang IC, Kalin TV, Major ML, Gusarova GA, Yoder HM, Costa RH, et al. Cancer Res 2006 66 2153 2161 10.1158/0008-5472.CAN-05-3003 16489016
17. FOXM1 upregulation is an early event in human squamous cell carcinoma and it is enhanced by nicotine during malignant transformation. Gemenetzidis E, Bose A, Riaz AM, Chaplin T, Young BD, Ali M, Sugden D, Thurlow JK, Cheong SC, Teo SH, et al. PLoS One 2009 4 4849 10.1371/journal.pone.0004849 19287496
18. Downstream targets of FOXM1: CEP55 and HELLS are cancer progression markers of head and neck squamous cell carcinoma. Waseem A, Ali M, Odell EW, Fortune F, Teh MT, Oral Oncol 2010 46 536 542 10.1016/j.oraloncology.2010.03.022 20400365
19. Maternal embryonic leucine zipper kinase (MELK) regulates multipotent neural progenitor proliferation. Nakano I, Paucar AA, Bajpai R, Dougherty JD, Zewail A, Kelly TK, Kim KJ, Ou J, Groszer M, Imura T, et al. J Cell Biol 2005 170 413 427 10.1083/jcb.200412115 16061694 (Pubitemid 41126941)
20. Gene expression analysis of hematopoietic progenitor cells identifies Dlg7 as a potential stem cell gene. Gudmundsson KO, Thorsteinsson L, Sigurjonsson OE, Keller JR, Olafsson K, Egeland T, Gudmundsson S, Rafson T, Stem Cells 2007 25 1498 1506 10.1634/stemcells.2005-0479 17322106 (Pubitemid 47106018)
21. PBK/TOPK, a proliferating neural progenitor-specific mitogen-activated protein kinase kinase. Dougherty JD, Garcia AD, Nakano I, Livingstone M, Norris B, Polakiewicz R, Wexler EM, Sofroniew MW, Kornblum HL, Geschwind DH, J Neurosci 2005 25 10773 10785 10.1523/JNEUROSCI.3207-05.2005 16291951 (Pubitemid 41681926)
22. Tramtrack controls glial number and identity in the drosophila embryonic CNS. Badenhorst P, Development 2001 128 4093 4101 11641231 (Pubitemid 33040615)
23. Profiling of genetic variations in inflammation pathway genes in relation to bladder cancer predisposition. Yang H, Gu J, Lin X, Grossman HB, Ye Y, Dinney CP, Wu X, Clin Cancer Res 2008 14 2236 2244 10.1158/1078-0432.CCR-07-1670 18381966 (Pubitemid 351551137)
24. Repeated BCG treatment of mouse bladder selectively stimulates small GTPases and HLA antigens and inhibits single-spanning uroplakins. Saban MR, Hellmich HL, Simpson C, Davis CA, Lang ML, Ihnat MA, O'Donnell MA, Wu XR, Saban R, BMC Cancer 2007 7 204 10.1186/1471-2407-7-204 17980030 (Pubitemid 351167701)
25. Strong interaction between the effects of alcohol consumption and smoking on oesophageal squamous cell carcinoma among individuals with ADH1B and/or ALDH2 risk alleles. Tanaka F, Yamamoto K, Suzuki S, Inoue H, Tsurumaru M, Kajiyama Y, Kato H, Igaki H, Furuta K, Fujita H, et al. Gut 2010 59 1457 1464 10.1136/gut.2009.205724 20833657
26. Increased EZH2 protein expression is associated with invasive urothelial carcinoma of the bladder. Wang H, Albadine R, Magheli A, Guzzo TJ, Ball MW, Hinz S, Schoenberg MP, Netto GJ, Gonzalgo ML, Urol Oncol 2012 30 428 433 10.1016/j.urolonc.2010.09.005 21396836
27. Repression of E-cadherin by the polycomb group protein EZH2 in cancer. Cao Q, Yu J, Dhanasekaran SM, Kim JH, Mani RS, Tomlins SA, Mehra R, Laxman B, Cao X, Yu J, Oncogene 2008 27 7274 7284 10.1038/onc.2008.333 18806826
28. Cadherin switching and bladder cancer. Bryan RT, Tselepis C, J Urol 2010 184 423 431 10.1016/j.juro.2010.04.016 20620393
29. Clinical outcomes following radical cystectomy for primary nontransitional cell carcinoma of the bladder compared to transitional cell carcinoma of the bladder. Rogers CG, Palapattu GS, Shariat SF, Karakiewicz PI, Bastian PJ, Lotan Y, Gupta A, Vazina A, Gilad A, Sagalowsky AI, et al. J Urol 2006 175 2048 2053 discussion 2053 10.1016/S0022-5347(06)00317-X 16697800 (Pubitemid 43668580)
30. Clinical outcome of a large-scale multi-institutional retrospective study for locally advanced bladder cancer: a survey including 1131 patients treated during 1990-2000 in Japan. Nishiyama H, Habuchi T, Watanabe J, Teramukai S, Tada H, Ono Y, Ohshima S, Fujimoto K, Hirao Y, Fukushima M, et al. Eur Urol 2004 45 176 181 10.1016/j.eururo.2003.09.011 14734003 (Pubitemid 38147824)
31. Epidermoid carcinoma of the bladder. Apropos of 14 cases. Debbagh A, Bennani S, Hafiani M, el Mrini M, Benjelloun S, Ann Urol (Paris) 1997 31 199 203 9412343 (Pubitemid 27421603)
32. Squamous cell carcinoma of the bladder. Johnson DE, Schoenwald MB, Ayala AG, Miller LS, J Urol 1976 115 542 544 1271546
33. Urothelial carcinoma versus squamous cell carcinoma of bladder: is survival different with stage adjustment? Scosyrev E, Yao J, Messing E, Urology 2009 73 822 827 10.1016/j.urology.2008.11.042 19193403
34. Squamous cell carcinoma of bladder. A review of 114 patients. Rundle JS, Hart AJ, McGeorge A, Smith JS, Malcolm AJ, Smith PM, Br J Urol 1982 54 522 526 10.1111/j.1464-410X.1982.tb13580.x 7171960 (Pubitemid 13204329)
35. A phase II study of gemcitabine plus cisplatin chemotherapy in advanced bilharzial bladder carcinoma. Khaled HM, Hamza MR, Mansour O, Gaafar R, Zaghloul MS, Eur J Cancer 2000 36 Suppl 2 34 37 10908847
36. Molecular genetic evidence for a common clonal origin of urinary bladder small cell carcinoma and coexisting urothelial carcinoma. Cheng L, Jones TD, McCarthy RP, Eble JN, Wang M, MacLennan GT, Lopez-Beltran A, Yang XJ, Koch MO, Zhang S, et al. Am J Pathol 2005 166 1533 1539 10.1016/S0002-9440(10)62369-3 15855652 (Pubitemid 40586521)